Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2013113680) RADIOLABELED BILE ACIDS AND BILE ACID DERIVATIVES
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2013/113680 International Application No.: PCT/EP2013/051635
Publication Date: 08.08.2013 International Filing Date: 29.01.2013
IPC:
A61K 51/04 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
51
Preparations containing radioactive substances for use in therapy or testing in vivo
02
characterised by the carrier
04
Organic compounds
Applicants:
AARHUS UNIVERSITET [DK/DK]; Nordre Ringgade 1 DK-8000 Aarhus C, DK
REGION MIDTJYLLAND [DK/DK]; Skottenborg 26 DK-8800 Viborg, DK
Inventors:
KEIDING, Susanne; DK
OTT, Peter; DK
SØRENSEN, Michael; DK
FRISCH, Kim; DK
HOFMANN, Alan; US
Agent:
HØIBERG A/S; St. Kongensgade 59 A DK-1264 Copenhagen K, DK
Priority Data:
61/594,43003.02.2012US
61/649,50421.05.2012US
Title (EN) RADIOLABELED BILE ACIDS AND BILE ACID DERIVATIVES
(FR) ACIDES BILIAIRES ET DÉRIVÉS D'ACIDES BILIAIRES RADIOMARQUÉS
Abstract:
(EN) The present invention relates in one aspect to radiolabeled compounds comprising the structure of Formula 1. The radiolabeled compounds are preferably bile acids or bile acid derivatives. Further aspects of the invention relates to use of the compounds comprising the structure of Formula 1 in imaging methods such as for example PET, imaging method using a compound comprising the structure of Formula 1, administering said compound to an individual and making a radiographic image of a region of interest from said individual.
(FR) La présente invention porte dans un aspect sur des composés radiomarqués comprenant la structure de formule 1. Les composés radiomarqués sont de préférence des acides biliaires ou des dérivés d'acides biliaires. D'autres aspects de l'invention portent sur l'utilisation des composés comprenant la structure de formule 1 dans des procédés d'imagerie tels que par exemple la TEP, sur un procédé d'imagerie utilisant un composé comprenant la structure de formule 1, sur l'administration dudit composé à un sujet et la formation d'une image radiographique d'une zone à examiner à partir dudit sujet.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)